\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ polyp\\ was\\ biopsied\\ and\\ sent\\ for\\ pathologic\\ diagnosis\\.\ \(0\)\
\-\ treatment\\ for\\ colorectal\\ carcinoma\\ depends\\ on\\ the\\ staging\\ of\\ the\\ disease\\.\\ \\ treatment\\ options\\ include\\ partial\\ or\\ total\\ colectomy\\,\\ radiation\\ therapy\\,\\ and\\ chemotherapy\\.\\ \\ radiation\\ therapy\\ may\\ be\\ used\\ before\\ surgery\\ to\\ shrink\\ the\\ tumor\\ or\\ after\\ surgery\\ as\\ an\\ adjuvant\\ therapy\\.\\ \\ if\\ the\\ cancerous\\ polyp\\ is\\ small\\,\\ generally\\ laparoscopic\\ surgery\\ is\\ utilized\\ due\\ to\\ the\\ decreased\\ amount\\ of\\ side\\-effects\\ and\\ healing\\ time\\ as\\ compared\\ to\\ open\\ surgery\\.\\ once\\ the\\ cancer\\ is\\ staged\\,\\ the\\ decision\\ to\\ use\\ chemotherapy\\ is\\ determined\\ by\\ presence\\ of\\ local\\ or\\ distal\\ metastasis\\.\\ \\(4\\)\ \(0\)\
\-\ virtual\\ colonoscopy\\ can\\ create\\ a\\ three\\ dimensional\\ \\(3d\\)\\ anatomic\\ model\\ of\\ the\\ colon\\ using\\ data\\ from\\ volumetrically\\ acquired\\ computed\\ tomography\\ \\(ct\\)\\ scan\\ \\(fig\\ 1a\\)\\.\\ \\ an\\ axial\\ slice\\ from\\ the\\ ct\\ scan\\ shows\\ a\\ 9\\ mm\\ pedunculated\\ polyp\\ in\\ the\\ sigmoid\\ colon\\,\\ approximately\\ 60\\ cm\\ from\\ the\\ anus\\ \\(fig\\.\\ 2a\\)\\.\\ \\ a\\ 3d\\ endoluminal\\ view\\ of\\ the\\ colon\\ shows\\ a\\ better\\ depiction\\ of\\ the\\ polyp\\ \\(fig\\.\\ 1b\\,\\ 2a\\,\\ 3\\,\\ 4a\\)\\.\ \(0\)\
\-\ examples\\ of\\ fly\\ through\\ vc\\ model\\ below\\ \\(not\\ actual\\ patient\\)\\:\ \(0\)\
\-\ a\\ flat\\ hyperplastic\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc1\\.avi\ \(0\)\
\-\ sessile\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc2\\.avi\ \(0\)\
\-\ tva\\ severe\\ dysplasia\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc3\\.avi\ \(0\)\
\-\ \\ \\ \\ \\ \\ the\\ patient\\ was\\ recommended\\ to\\ undergo\\ optical\\ colonoscopy\\ \\(oc\\)\\ to\\ confirm\\ the\\ presence\\ of\\ the\\ polyp\\.\\ the\\ oc\\ confirmed\\ the\\ presence\\ of\\ a\\ 1\\.5\\ cm\\ pedunculated\\ polyp\\,\\ located\\ 50\\ cm\\ from\\ the\\ anus\\ \\(fig\\.\\ 4b\\)\\.\ \(0\)\
\-\ invasive\\ colonic\\ adenocarcinoma\\:\ \(0\)\
\-\ biopsy\\ of\\ the\\ polyp\\ showed\\ micro\\-invasive\\ colonic\\ adenocarcinoma\\,\\ without\\ invasion\\ of\\ the\\ lymphatic\\,\\ vascular\\,\\ or\\ perineural\\ space\\.\ \(0\)\
\-\ \\â\\€\\¢\\ invasive\\ colonic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ intramucosal\\ colonic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ adenoma\\ \\(tubular\\,\\ villous\\,\\ and\\ tubulovillous\\)\ \(0\)\
\-\ \\â\\€\\¢\\ hyperplastic\\ polyp\\ \ \(0\)\
\-\ \\â\\€\\¢\\ fibroblastic\\ polyp\ \(0\)\
\-\ \\â\\€\\¢\\ inflammatory\\ polyp\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoid\\ polyp\ \(0\)\
\-\ a\\ 51\\-year\\-old\\ male\\ with\\ no\\ known\\ symptoms\\ undergoes\\ with\\ routine\\ screening\\ for\\ colorectal\\ carcinoma\\ with\\ virtual\\ colonoscopy\\.\ \(0\)\
\-\ colon\\ cancer\\ is\\ the\\ third\\ most\\ diagnosed\\ \\(1\\)\\ malignant\\ neoplasm\\ and\\ second\\ leading\\ cause\\ of\\ cancer\\ related\\ mortality\\ in\\ the\\ united\\ states\\.\\ \\(2\\)\\ \\ despite\\ being\\ so\\ deadly\\,\\ colorectal\\ carcinoma\\ is\\ also\\ one\\ of\\ the\\ most\\ preventable\\ types\\ of\\ cancer\\.\\ \\ it\\ is\\ generally\\ recommended\\ that\\ all\\ men\\ and\\ women\\ over\\ the\\ age\\ of\\ 50\\ get\\ colon\\ cancer\\ screening\\ every\\ 5\\ to\\ 10\\ years\\.\\ \\(5\\)\\ \\ however\\,\\ it\\ is\\ noted\\ that\\ only\\ approximately\\ 30\\%\\ of\\ people\\ eligible\\ to\\ get\\ screened\\ actually\\ get\\ screened\\.\\ \\(6\\)\\ this\\ statistic\\ is\\ important\\ because\\ the\\ latency\\ period\\ for\\ colorectal\\ carcinoma\\ is\\ 10\\ to\\ 20\\ years\\.\\ \\ the\\ traditional\\ gold\\ standard\\ for\\ colorectal\\ screening\\ has\\ been\\ oc\\,\\ which\\ is\\ invasive\\,\\ requires\\ sedation\\,\\ and\\ a\\ full\\ bowel\\ cleanse\\ the\\ day\\ before\\.\\ this\\ may\\ be\\ too\\ overwhelming\\ for\\ asymptomatic\\ individuals\\ that\\ should\\ be\\ screened\\.\\ \\ one\\ hope\\ is\\ that\\ vc\\ will\\ help\\ make\\ the\\ screening\\ process\\ more\\ convenient\\ without\\ jeopardizing\\ the\\ sensitivity\\ and\\ specificity\\ of\\ the\\ test\\.\ \(0\)\
\-\ computed\\ tomography\\ \\(ct\\)\\ colonography\\ or\\ vc\\ is\\ a\\ technique\\ that\\ utilizes\\ volumetrically\\ acquired\\ helical\\ ct\\ scan\\ of\\ the\\ abdomen\\ to\\ produce\\ two\\-dimensional\\ and\\ three\\ dimensional\\ images\\ of\\ the\\ colon\\.\\ \\(6\\)\\ \\ these\\ images\\ can\\ detect\\ colon\\ polyps\\ of\\ varying\\ sizes\\.\\ \\ to\\ get\\ the\\ best\\ image\\ of\\ the\\ colon\\,\\ carbon\\ dioxide\\ is\\ used\\ to\\ inflate\\ the\\ colon\\ through\\ a\\ flexible\\ rectal\\ tube\\ \\(about\\ the\\ size\\ of\\ a\\ pencil\\)\\.\ \(0\)\
\-\ differential\\ considerations\\ for\\ a\\ polyp\\ in\\ the\\ colon\\ include\\:\\ hyperplastic\\ polyp\\,\\ fibroblastic\\ polyp\\,\\ inflammatory\\ polyp\\,\\ lymphoid\\ polyp\\,\\ adenoma\\ \\(tubular\\,\\ villous\\,\\ and\\ tubulovillous\\)\\,\\ intramucosal\\ colonic\\ adenocarcinoma\\,\\ and\\ invasive\\ colonic\\ adenocarcinoma\\.\\ \\ a\\ hyperplastic\\ polyp\\ is\\ a\\ benign\\ growth\\ of\\ the\\ colonic\\ endothelium\\.\\ \\ adenomas\\ are\\ neoplastic\\ benign\\ growths\\ of\\ the\\ colonic\\ epithelium\\ that\\ are\\ direct\\ precursors\\ to\\ adenocarcinoma\\.\\ \\ tubular\\ adenomas\\ arise\\ from\\ tubular\\ glands\\ of\\ the\\ colon\\ wall\\ and\\ account\\ for\\ a\\ majority\\ of\\ adenomas\\ found\\ in\\ the\\ colon\\.\\ \\ villous\\ adenomas\\ develop\\ from\\ the\\ villous\\ projections\\ and\\ only\\ make\\ up\\ 1\\%\\ of\\ adenomas\\ found\\ within\\ the\\ colon\\.\\ \\ tubulovillous\\ adenomas\\ are\\ a\\ combination\\ of\\ tubular\\ and\\ villous\\ adenomas\\ and\\ account\\ for\\ 5\\%\\ to\\ 10\\%\\ of\\ adenomas\\ discovered\\.\\ \\ intramucosal\\ carcinomas\\ are\\ malignant\\ cells\\ confined\\ to\\ the\\ bowel\\ mucosa\\.\\ \\ invasive\\ carcinomas\\ occur\\ when\\ these\\ malignant\\ cells\\ extend\\ into\\ the\\ submucosa\\ of\\ the\\ colon\\ wall\\.\\ \\(3\\)\\ \\ \ \(0\)\
\-\ in\\ conclusion\\,\\ vc\\ is\\ a\\ minimally\\ invasive\\ alternative\\ for\\ colorectal\\ screening\\ that\\ has\\ the\\ potential\\ to\\ greatly\\ increase\\ compliance\\.\\ \\ there\\ is\\ a\\ national\\ study\\ in\\ progress\\ being\\ conducted\\ by\\ the\\ american\\ college\\ of\\ radiology\\ imaging\\ network\\ \\(acrin\\)\\ \\(12\\)\\ to\\ confirm\\ the\\ positive\\ findings\\ from\\ the\\ earlier\\ department\\ of\\ defense\\ \\(dod\\)\\ study\\.\\ the\\ authors\\ believe\\ that\\ vc\\ will\\ have\\ a\\ large\\ positive\\ impact\\ on\\ public\\ health\\ because\\ early\\ detection\\ of\\ colon\\ cancer\\ should\\ substantially\\ reduce\\ the\\ mortality\\ from\\ colon\\ cancer\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polyp\\:\\ 0\\.11458833228233381\ \(0\)\
\-\ colon\\:\\ 0\\.06324490760560357\ \(0\)\
\-\ adenomas\\:\\ 0\\.05352201845029304\ \(0\)\
\-\ vc\\:\\ 0\\.051917069634667246\ \(0\)\
\-\ colonic\\:\\ 0\\.043878778238933575\ \(0\)\
\-\ villous\\:\\ 0\\.043752791889556\ \(0\)\
\-\ colorectal\\:\\ 0\\.04364990172686388\ \(0\)\
\-\ intramucosal\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.03043684465482058\ \(0\)\
\-\ invasive\\:\\ 0\\.030344380543586274\ \(0\)\
\-\ oc\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ hyperplastic\\:\\ 0\\.027915885352510404\ \(0\)\
\-\ tubulovillous\\:\\ 0\\.026251675133733596\ \(0\)\
\-\ fig\\:\\ 0\\.024919471846173553\ \(0\)\
\-\ get\\:\\ 0\\.024650174254465904\ \(0\)\
\-\ screened\\:\\ 0\\.02380239181020022\ \(0\)\
\-\ tubular\\:\\ 0\\.023434844034246293\ \(0\)\
\-\ cancer\\:\\ 0\\.023161551060722447\ \(0\)\
\-\ screening\\:\\ 0\\.0214666338570574\ \(0\)\
\-\ volumetrically\\:\\ 0\\.020766827853866895\ \(0\)\
\-\ dimensional\\:\\ 0\\.019133972304844645\ \(0\)\
\-\ \\(\\:\\ 0\\.018718442847308517\ \(0\)\
\-\ \\)\\:\\ 0\\.01848978707478529\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.017621473595326512\ \(0\)\
\-\ 2a\\:\\ 0\\.016975454679699405\ \(0\)\
\-\ fibroblastic\\:\\ 0\\.016975454679699405\ \(0\)\
\-\ model\\:\\ 0\\.015868261206800145\ \(0\)\
\-\ virtual\\:\\ 0\\.01472454432627788\ \(0\)\
\-\ lymphoid\\:\\ 0\\.014235405657777894\ \(0\)\
\-\ that\\:\\ 0\\.013907945616573129\ \(0\)\
\-\ 3d\\:\\ 0\\.013830575841696249\ \(0\)\
\-\ anus\\:\\ 0\\.013485220189889709\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.012920024100319451\ \(0\)\
\-\ carcinomas\\:\\ 0\\.012917111693265709\ \(0\)\
\-\ pedunculated\\:\\ 0\\.012754584316382432\ \(0\)\
\-\ \\:\\:\\ 0\\.011981711830289737\ \(0\)\
\-\ from\\:\\ 0\\.011933434281782918\ \(0\)\
\-\ http\\:\\ 0\\.011433881971661753\ \(0\)\
\-\ carcinoma\\:\\ 0\\.011410731071923988\ \(0\)\
\-\ account\\:\\ 0\\.011369927861960479\ \(0\)\
\-\ is\\:\\ 0\\.01125906152242678\ \(0\)\
\-\ mortality\\:\\ 0\\.010969694559733394\ \(0\)\
\-\ presence\\:\\ 0\\.010960373210095862\ \(0\)\
\-\ malignant\\:\\ 0\\.010914030658584102\ \(0\)\
\-\ acquired\\:\\ 0\\.010792489798278536\ \(0\)\
\-\ tomography\\:\\ 0\\.010758594068120467\ \(0\)\
\-\ make\\:\\ 0\\.010758594068120467\ \(0\)\
\-\ computed\\:\\ 0\\.010627687469404777\ \(0\)\
\-\ \\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc1\\.avi\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ \\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc2\\.avi\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ tva\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ \\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc3\\.avi\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ micro\\-invasive\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ statistic\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ cleanse\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ convenient\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ jeopardizing\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ inflate\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ growths\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ acrin\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ defense\\:\\ 0\\.010383413926933448\ \(0\)\
\-\ confirm\\:\\ 0\\.010246431814633484\ \(0\)\
\-\ 10\\:\\ 0\\.01017888419910569\ \(0\)\
\-\ surgery\\:\\ 0\\.009776202894512484\ \(0\)\
\-\ side\\-effects\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ 4a\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ 4b\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ latency\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ precursors\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ dod\\:\\ 0\\.009566986152422323\ \(0\)\
\-\ \\%\\:\\ 0\\.009391382960405217\ \(0\)\
\-\ \\,\\:\\ 0\\.009246869140166472\ \(0\)\
\-\ deadly\\:\\ 0\\.009089406519786087\ \(0\)\
\-\ preventable\\:\\ 0\\.009089406519786087\ \(0\)\
\-\ utilizes\\:\\ 0\\.009089406519786087\ \(0\)\
\-\ pencil\\:\\ 0\\.009089406519786087\ \(0\)\
\-\ generally\\:\\ 0\\.009059376029188451\ \(0\)\
\-\ a\\:\\ 0\\.008875613939403327\ \(0\)\
\-\ 5\\:\\ 0\\.008834489125244394\ \(0\)\
\-\ the\\:\\ 0\\.008793240723198812\ \(0\)\
\-\ fly\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ optical\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ 51\\-year\\-old\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ two\\-dimensional\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ dioxide\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ endothelium\\:\\ 0\\.008750558377911197\ \(0\)\
\-\ for\\:\\ 0\\.008587846273765786\ \(0\)\
\-\ to\\:\\ 0\\.008551422666113978\ \(0\)\
\-\ before\\:\\ 0\\.008520662880331384\ \(0\)\
\-\ cancerous\\:\\ 0\\.008487727339849703\ \(0\)\
\-\ 1b\\:\\ 0\\.008487727339849703\ \(0\)\
\-\ network\\:\\ 0\\.008487727339849703\ \(0\)\
\-\ public\\:\\ 0\\.008487727339849703\ \(0\)\
\-\ scan\\:\\ 0\\.008453256043932785\ \(0\)\
\-\ adenoma\\:\\ 0\\.008406347118506506\ \(0\)\
\-\ recommended\\:\\ 0\\.008345156337815669\ \(0\)\
\-\ endoluminal\\:\\ 0\\.008272978745274962\ \(0\)\
\-\ depiction\\:\\ 0\\.008272978745274962\ \(0\)\
\-\ overwhelming\\:\\ 0\\.008272978745274962\ \(0\)\
\-\ colonography\\:\\ 0\\.008272978745274962\ \(0\)\
\-\ cm\\:\\ 0\\.008098784868611257\ \(0\)\
\-\ shrink\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ 1a\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ slice\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ eligible\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ flexible\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ submucosa\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ substantially\\:\\ 0\\.008091411395655106\ \(0\)\
\-\ therapy\\:\\ 0\\.008072935675761884\ \(0\)\
\-\ cells\\:\\ 0\\.008071723661130735\ \(0\)\
\-\ staged\\:\\ 0\\.007934130603400072\ \(0\)\
\-\ perineural\\:\\ 0\\.007934130603400072\ \(0\)\
\-\ hope\\:\\ 0\\.007934130603400072\ \(0\)\
\-\ compliance\\:\\ 0\\.007934130603400072\ \(0\)\
\-\ used\\:\\ 0\\.007722459733681888\ \(0\)\
\-\ undergoes\\:\\ 0\\.007671299565338577\ \(0\)\
\-\ 50\\:\\ 0\\.007658417000338762\ \(0\)\
\-\ sedation\\:\\ 0\\.007456550970763837\ \(0\)\
\-\ traditional\\:\\ 0\\.00736227216313894\ \(0\)\
\-\ helical\\:\\ 0\\.00736227216313894\ \(0\)\
\-\ examples\\:\\ 0\\.00727498362114398\ \(0\)\
\-\ actual\\:\\ 0\\.00727498362114398\ \(0\)\
\-\ conclusion\\:\\ 0\\.00727498362114398\ \(0\)\
\-\ college\\:\\ 0\\.00727498362114398\ \(0\)\
\-\ believe\\:\\ 0\\.00727498362114398\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.007215419988553275\ \(0\)\
\-\ create\\:\\ 0\\.007117702828888947\ \(0\)\
\-\ sessile\\:\\ 0\\.007117702828888947\ \(0\)\
\-\ national\\:\\ 0\\.007117702828888947\ \(0\)\
\-\ colectomy\\:\\ 0\\.0070462957360545135\ \(0\)\
\-\ because\\:\\ 0\\.007042445975467721\ \(0\)\
\-\ being\\:\\ 0\\.007014812666196839\ \(0\)\
\-\ inflammatory\\:\\ 0\\.006980720716588984\ \(0\)\
\-\ carbon\\:\\ 0\\.006978971338127601\ \(0\)\
\-\ greatly\\:\\ 0\\.006978971338127601\ \(0\)\
\-\ benign\\:\\ 0\\.006947115116685986\ \(0\)\
\-\ biopsied\\:\\ 0\\.0068548717908274515\ \(0\)\
\-\ alternative\\:\\ 0\\.0068548717908274515\ \(0\)\
\-\ three\\:\\ 0\\.006785922799403793\ \(0\)\
\-\ adjuvant\\:\\ 0\\.0067426100949448545\ \(0\)\
\-\ projections\\:\\ 0\\.0067426100949448545\ \(0\)\
\-\ authors\\:\\ 0\\.0067426100949448545\ \(0\)\
\-\ depends\\:\\ 0\\.00669025230628663\ \(0\)\
\-\ lymphatic\\:\\ 0\\.00669025230628663\ \(0\)\
\-\ people\\:\\ 0\\.00669025230628663\ \(0\)\
\-\ gold\\:\\ 0\\.006640123196252711\ \(0\)\
\-\ conducted\\:\\ 0\\.006640123196252711\ \(0\)\
\-\ study\\:\\ 0\\.006623395422520516\ \(0\)\
\-\ radiation\\:\\ 0\\.006606010010747553\ \(0\)\
\-\ sizes\\:\\ 0\\.006592040752765956\ \(0\)\
\-\ epithelium\\:\\ 0\\.006592040752765956\ \(0\)\
\-\ decision\\:\\ 0\\.006545844388627815\ \(0\)\
\-\ specificity\\:\\ 0\\.006545844388627815\ \(0\)\
\-\ positive\\:\\ 0\\.006532121531882489\ \(0\)\
\-\ should\\:\\ 0\\.006417452395497762\ \(0\)\
\-\ utilized\\:\\ 0\\.006377292158191216\ \(0\)\
\-\ found\\:\\ 0\\.006343994380334775\ \(0\)\
\-\ bowel\\:\\ 0\\.006313200313038302\ \(0\)\
\-\ will\\:\\ 0\\.006297952929043915\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.006265030462308619\ \(0\)\
\-\ approximately\\:\\ 0\\.006228074974218099\ \(0\)\
\-\ united\\:\\ 0\\.006195724808571359\ \(0\)\
\-\ actually\\:\\ 0\\.006195724808571359\ \(0\)\
\-\ detect\\:\\ 0\\.006098860146336999\ \(0\)\
\-\ polyps\\:\\ 0\\.006098860146336999\ \(0\)\
\-\ confined\\:\\ 0\\.00606826475599158\ \(0\)\
\-\ only\\:\\ 0\\.0060527954263484935\ \(0\)\
\-\ 6\\:\\ 0\\.006012061628680504\ \(0\)\
\-\ glands\\:\\ 0\\.005980976213996619\ \(0\)\
\-\ impact\\:\\ 0\\.005980976213996619\ \(0\)\
\-\ years\\:\\ 0\\.005911055682022337\ \(0\)\
\-\ flat\\:\\ 0\\.00589971252555498\ \(0\)\
\-\ varying\\:\\ 0\\.00589971252555498\ \(0\)\
\-\ or\\:\\ 0\\.005898249404968831\ \(0\)\
\-\ individuals\\:\\ 0\\.0058738245317755036\ \(0\)\
\-\ detection\\:\\ 0\\.005848493312433969\ \(0\)\
\-\ wall\\:\\ 0\\.005830763534131322\ \(0\)\
\-\ staging\\:\\ 0\\.005799408864376762\ \(0\)\
\-\ technique\\:\\ 0\\.005799408864376762\ \(0\)\
\-\ considerations\\:\\ 0\\.005799408864376762\ \(0\)\
\-\ through\\:\\ 0\\.005717213235384849\ \(0\)\
\-\ rectal\\:\\ 0\\.005706980577637664\ \(0\)\
\-\ men\\:\\ 0\\.005684963930980239\ \(0\)\
\-\ sensitivity\\:\\ 0\\.005684963930980239\ \(0\)\
\-\ progress\\:\\ 0\\.005684963930980239\ \(0\)\
\-\ reduce\\:\\ 0\\.005684963930980239\ \(0\)\
\-\ include\\:\\ 0\\.005647004683228002\ \(0\)\
\-\ too\\:\\ 0\\.005642128072121729\ \(0\)\
\-\ ct\\:\\ 0\\.005631583761564395\ \(0\)\
\-\ produce\\:\\ 0\\.005580660753899621\ \(0\)\
\-\ health\\:\\ 0\\.005580660753899621\ \(0\)\
\-\ shows\\:\\ 0\\.00553444923375472\ \(0\)\
\-\ are\\:\\ 0\\.005488216124992234\ \(0\)\
\-\ one\\:\\ 0\\.005455197604972071\ \(0\)\
\-\ data\\:\\ 0\\.005448602687797494\ \(0\)\
\-\ every\\:\\ 0\\.005346115789105351\ \(0\)\
\-\ requires\\:\\ 0\\.005346115789105351\ \(0\)\
\-\ mucosa\\:\\ 0\\.005313843734702389\ \(0\)\
\-\ determined\\:\\ 0\\.005251836981480455\ \(0\)\
\-\ these\\:\\ 0\\.005238738968098563\ \(0\)\
\-\ minimally\\:\\ 0\\.005236832239693141\ \(0\)\
\-\ healing\\:\\ 0\\.005192931892464363\ \(0\)\
\-\ better\\:\\ 0\\.005192931892464363\ \(0\)\
\-\ once\\:\\ 0\\.005150609148970768\ \(0\)\
\-\ standard\\:\\ 0\\.005150609148970768\ \(0\)\
\-\ neoplastic\\:\\ 0\\.005150609148970768\ \(0\)\
\-\ types\\:\\ 0\\.005136832894832732\ \(0\)\
\-\ sent\\:\\ 0\\.005123215907316742\ \(0\)\
\-\ sigmoid\\:\\ 0\\.005123215907316742\ \(0\)\
\-\ undergo\\:\\ 0\\.005109754545922604\ \(0\)\
\-\ anatomic\\:\\ 0\\.005083284751043855\ \(0\)\
\-\ combination\\:\\ 0\\.005070269631860599\ \(0\)\
\-\ extend\\:\\ 0\\.005044663051605703\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.005032065537922844\ \(0\)\
\-\ help\\:\\ 0\\.005019601333764378\ \(0\)\
\-\ develop\\:\\ 0\\.005019601333764378\ \(0\)\
\-\ arise\\:\\ 0\\.004982981089865637\ \(0\)\
\-\ earlier\\:\\ 0\\.004971023055161258\ \(0\)\
\-\ discovered\\:\\ 0\\.004959185203743706\ \(0\)\
\-\ majority\\:\\ 0\\.004947465143845982\ \(0\)\
\-\ options\\:\\ 0\\.004890552803126539\ \(0\)\
\-\ women\\:\\ 0\\.004890552803126539\ \(0\)\
\-\ invasion\\:\\ 0\\.004846923507861109\ \(0\)\
\-\ potential\\:\\ 0\\.004846923507861109\ \(0\)\
\-\ leading\\:\\ 0\\.004815230394881222\ \(0\)\
\-\ american\\:\\ 0\\.004794565719202883\ \(0\)\
\-\ 1\\:\\ 0\\.0047899325511418294\ \(0\)\
\-\ direct\\:\\ 0\\.00475429320477617\ \(0\)\
\-\ without\\:\\ 0\\.004739724773517456\ \(0\)\
\-\ states\\:\\ 0\\.004734661811978512\ \(0\)\
\-\ 3\\:\\ 0\\.004713723266682072\ \(0\)\
\-\ period\\:\\ 0\\.004705814909730814\ \(0\)\
\-\ despite\\:\\ 0\\.0046776576413520695\ \(0\)\
\-\ be\\:\\ 0\\.004656384181427311\ \(0\)\
\-\ most\\:\\ 0\\.004647432607133277\ \(0\)\
\-\ local\\:\\ 0\\.004623285389569781\ \(0\)\
\-\ so\\:\\ 0\\.004579817124628143\ \(0\)\
\-\ can\\:\\ 0\\.0045658948232486915\ \(0\)\
\-\ of\\:\\ 0\\.004528416285434179\ \(0\)\
\-\ it\\:\\ 0\\.004524966748016529\ \(0\)\
\-\ important\\:\\ 0\\.004521536727380357\ \(0\)\
\-\ department\\:\\ 0\\.004513441463201604\ \(0\)\
\-\ open\\:\\ 0\\.004473779254595493\ \(0\)\
\-\ may\\:\\ 0\\.004415378960890751\ \(0\)\
\-\ pathologic\\:\\ 0\\.004405588467294077\ \(0\)\
\-\ 60\\:\\ 0\\.004390956523832879\ \(0\)\
\-\ growth\\:\\ 0\\.004376504117953238\ \(0\)\
\-\ using\\:\\ 0\\.004369343875224873\ \(0\)\
\-\ below\\:\\ 0\\.004369343875224873\ \(0\)\
\-\ full\\:\\ 0\\.0043481206649743686\ \(0\)\
\-\ total\\:\\ 0\\.0043341813744596416\ \(0\)\
\-\ test\\:\\ 0\\.004300038221487614\ \(0\)\
\-\ compared\\:\\ 0\\.004260331440165692\ \(0\)\
\-\ radiology\\:\\ 0\\.004253841857349473\ \(0\)\
\-\ tube\\:\\ 0\\.004240968982753253\ \(0\)\
\-\ best\\:\\ 0\\.004234584922129768\ \(0\)\
\-\ increase\\:\\ 0\\.0042219196785770454\ \(0\)\
\-\ amount\\:\\ 0\\.004203173559253253\ \(0\)\
\-\ 9\\:\\ 0\\.004160559122766206\ \(0\)\
\-\ related\\:\\ 0\\.004154595280650133\ \(0\)\
\-\ located\\:\\ 0\\.004142757429232581\ \(0\)\
\-\ 12\\:\\ 0\\.004119432779884902\ \(0\)\
\-\ treatment\\:\\ 0\\.004074480470202325\ \(0\)\
\-\ routine\\:\\ 0\\.004035861830565367\ \(0\)\
\-\ third\\:\\ 0\\.004035861830565367\ \(0\)\
\-\ partial\\:\\ 0\\.004025153972260006\ \(0\)\
\-\ use\\:\\ 0\\.003978137944691758\ \(0\)\
\-\ dysplasia\\:\\ 0\\.003973027931030276\ \(0\)\
\-\ about\\:\\ 0\\.0038799263911710857\ \(0\)\
\-\ process\\:\\ 0\\.0038752243637629144\ \(0\)\
\-\ 30\\:\\ 0\\.003870541032338133\ \(0\)\
\-\ second\\:\\ 0\\.003865876248809161\ \(0\)\
\-\ images\\:\\ 0\\.003861634610010257\ \(0\)\
\-\ confirmed\\:\\ 0\\.003784922971833683\ \(0\)\
\-\ has\\:\\ 0\\.003780211944627274\ \(0\)\
\-\ view\\:\\ 0\\.003776262224713237\ \(0\)\
\-\ occur\\:\\ 0\\.003776262224713237\ \(0\)\
\-\ metastasis\\:\\ 0\\.0037676646952884882\ \(0\)\
\-\ mm\\:\\ 0\\.0037010543660718556\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0037010543660718556\ \(0\)\
\-\ early\\:\\ 0\\.0036809881856801384\ \(0\)\
\-\ 20\\:\\ 0\\.0036189814324582045\ \(0\)\
\-\ biopsy\\:\\ 0\\.0035708989889714493\ \(0\)\
\-\ neoplasm\\:\\ 0\\.003427746261380363\ \(0\)\
\-\ cause\\:\\ 0\\.00340549190406592\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.003402346758534849\ \(0\)\
\-\ size\\:\\ 0\\.003374412098208211\ \(0\)\
\-\ by\\:\\ 0\\.0033518749193047694\ \(0\)\
\-\ space\\:\\ 0\\.0033292779824224197\ \(0\)\
\-\ showed\\:\\ 0\\.0033001216347746717\ \(0\)\
\-\ vascular\\:\\ 0\\.0033001216347746717\ \(0\)\
\-\ day\\:\\ 0\\.0031954768308043928\ \(0\)\
\-\ differential\\:\\ 0\\.0031954768308043928\ \(0\)\
\-\ known\\:\\ 0\\.003184983609498021\ \(0\)\
\-\ and\\:\\ 0\\.003180371126010927\ \(0\)\
\-\ image\\:\\ 0\\.003143921279502474\ \(0\)\
\-\ severe\\:\\ 0\\.003096949116685517\ \(0\)\
\-\ age\\:\\ 0\\.00306349861665996\ \(0\)\
\-\ as\\:\\ 0\\.003044941121069794\ \(0\)\
\-\ decreased\\:\\ 0\\.002992645939604899\ \(0\)\
\-\ abdomen\\:\\ 0\\.002981606905648641\ \(0\)\
\-\ in\\:\\ 0\\.002978072297810989\ \(0\)\
\-\ when\\:\\ 0\\.002882604520160195\ \(0\)\
\-\ axial\\:\\ 0\\.002872545908207151\ \(0\)\
\-\ all\\:\\ 0\\.0028467885623454543\ \(0\)\
\-\ time\\:\\ 0\\.0028428754148872937\ \(0\)\
\-\ 4\\:\\ 0\\.0028044427622839164\ \(0\)\
\-\ however\\:\\ 0\\.0028025536579470794\ \(0\)\
\-\ an\\:\\ 0\\.0027836628133915894\ \(0\)\
\-\ been\\:\\ 0\\.002738274310322722\ \(0\)\
\-\ distal\\:\\ 0\\.0027364883262026227\ \(0\)\
\-\ if\\:\\ 0\\.0027311465651126444\ \(0\)\
\-\ up\\:\\ 0\\.0027065337468247623\ \(0\)\
\-\ due\\:\\ 0\\.002685838813843156\ \(0\)\
\-\ over\\:\\ 0\\.002562594334676045\ \(0\)\
\-\ more\\:\\ 0\\.0025172865834065562\ \(0\)\
\-\ symptoms\\:\\ 0\\.002508430479267537\ \(0\)\
\-\ into\\:\\ 0\\.0023949662755709147\ \(0\)\
\-\ noted\\:\\ 0\\.002385655110073726\ \(0\)\
\-\ imaging\\:\\ 0\\.0023581552702657276\ \(0\)\
\-\ tumor\\:\\ 0\\.002346563370566326\ \(0\)\
\-\ was\\:\\ 0\\.002328097814402089\ \(0\)\
\-\ small\\:\\ 0\\.0023186988037469003\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0023112124037460774\ \(0\)\
\-\ this\\:\\ 0\\.002264163046676403\ \(0\)\
\-\ large\\:\\ 0\\.0022008744780106946\ \(0\)\
\-\ have\\:\\ 0\\.002179550151195632\ \(0\)\
\-\ 2\\:\\ 0\\.002167378676690867\ \(0\)\
\-\ findings\\:\\ 0\\.0021423285462779263\ \(0\)\
\-\ after\\:\\ 0\\.002082451357608012\ \(0\)\
\-\ patient\\:\\ 0\\.002017884407341314\ \(0\)\
\-\ also\\:\\ 0\\.0019842398040873393\ \(0\)\
\-\ within\\:\\ 0\\.0019200605516914977\ \(0\)\
\-\ which\\:\\ 0\\.0018788511039370419\ \(0\)\
\-\ male\\:\\ 0\\.001820030079961688\ \(0\)\
\-\ on\\:\\ 0\\.0017052791810728575\ \(0\)\
\-\ disease\\:\\ 0\\.0016451561145061297\ \(0\)\
\-\ \\.\\:\\ 0\\.001588907387160375\ \(0\)\
\-\ there\\:\\ 0\\.0014978981819375602\ \(0\)\
\-\ not\\:\\ 0\\.001454438953759641\ \(0\)\
\-\ no\\:\\ 0\\.001013479565022146\ \(0\)\
\-\ with\\:\\ 0\\.00041344231833883297\ \(0\)\
